Vasculitis/Diffuse Alveolar Hemorrhage - Management

MANAGEMENT OF DAH1

  • Recommendations for management are disease specific once an underlying cause is identified
    • Non-immune mediated causes are managed by treating the systemic disease
    • Although there are no approved therapies, immune-mediated cases are typically managed by the immediate administration of high-dose glucocorticoids
  • Supportive care including ventilatory support (e.g., oxygen supplementation, mechanical ventilation)

See also

Test your Knowledge
Test your knowledge

Take the test

Lung X-Ray Example
Rad Rounds Mobile App

Download the app

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media